MIGNONE ROBERTO (CIK 1258394) reported 15 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-23). Recent activity: Buy GH (264 shares), Buy GH (264 shares), Buy GH (4,203 shares), Buy TEVA (14,492 shares), Buy GH (264 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | Guardant Health, Inc. (GH) | Director | Buy | 264 | $0 |
| 2026-06-23 | Guardant Health, Inc. (GH) | Director | Buy | 264 | $0 |
| 2026-06-22 | Guardant Health, Inc. (GH) | Director | Buy | 4,203 | $0 |
| 2026-06-08 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Director | Buy | 14,492 | $0 |
| 2026-04-22 | Guardant Health, Inc. (GH) | Director | Buy | 264 | $0 |
| 2026-03-23 | Guardant Health, Inc. (GH) | Director | Buy | 264 | $0 |
| 2026-02-23 | Guardant Health, Inc. (GH) | Director | Buy | 264 | $0 |
| 2026-01-22 | Guardant Health, Inc. (GH) | Director | Buy | 264 | $0 |
| 2025-12-23 | Guardant Health, Inc. (GH) | Director | Buy | 264 | $0 |
| 2025-12-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Director | Sell | 77,400 | $2.3M |
| 2025-12-01 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Director | Sell | 50,000 | $1.3M |
| 2025-11-24 | Guardant Health, Inc. (GH) | Director | Buy | 264 | $0 |
| 2025-11-10 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Director | Sell | 200,000 | $4.8M |
| 2025-10-22 | Guardant Health, Inc. (GH) | Director | Buy | 3,167 | $0 |
| 2025-06-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Director | Buy | 9,632 | $0 |
Source: SEC Form 4 filings · as of 2026-06-23